Skip to main content
Clinical Trials/NCT04620564
NCT04620564
Active, not recruiting
Not Applicable

Longitudinal Analysis of Mental Disorders, Psychosocial Distress and Psycho-oncological Care Needs of Patients and Their Relatives Stratified by Biopsychosocial Factors (LUPE)

University of Leipzig1 site in 1 country2,000 target enrollmentJanuary 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Neoplasm Malignant
Sponsor
University of Leipzig
Enrollment
2000
Locations
1
Primary Endpoint
Prevalence of mental disorders according to the DSM-5 (objective need for psycho-oncological support) in cancer patients and the changes over time
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

The primary objectives of this prospective observational multicenter study LUPE are to assess the prevalence of mental disorders according to the DSM-5 (objective need for psycho-oncological support), psychosocial distress, psycho-oncological care needs and utilization of psycho-oncological support services (subjective need for support) of cancer patients and their relatives during the first months of cancer survivorship stratified by biopsychosocial factors including socioeconomic status. The investigators further aim to identify moderating and mediating as well as associated factors for psychological distress and supportive care needs.

LUPE will include 2000 adult patients with solid tumor entities and one relative per patient at 4 measurement points from time of diagnosis to follow-up (+18 months) (t1: after diagnosis, t2: 6 month later, t3: 6 month later, t4: 6 month later).

The investigators aim to generate a quota sample according to socioeconomic status (SES) that is representative of the German overall population.

All participants will receive validated self-report questionnaires. Cancer patients will be interviewed using the standardized clinical interview SCID-5.

Registry
clinicaltrials.gov
Start Date
January 1, 2020
End Date
December 31, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University of Leipzig
Responsible Party
Principal Investigator
Principal Investigator

Anja Mehnert

Prof

University of Leipzig

Eligibility Criteria

Inclusion Criteria

  • Primary diagnosis of malignant solid tumor
  • a maximum time period after diagnosis of 4-8 weeks
  • minimum age of 18 years
  • cognitive ability to consent to study participation

Exclusion Criteria

  • presence of hematological cancers
  • patients with cancer recurrence

Outcomes

Primary Outcomes

Prevalence of mental disorders according to the DSM-5 (objective need for psycho-oncological support) in cancer patients and the changes over time

Time Frame: after the diagnosis (up to 8 weeks) and at every follow up (Month 6, Month 12, Month 18)

SCID (Structured Clinical Interview)

Frequency and extent of psychological distress (Anxiety) (subjective psycho-oncological support needs) in cancer patients and their relatives and the changes over time

Time Frame: after the diagnosis (up to 8 weeks) and at every follow up (Month 6, Month 12, Month 18)

GAD (Generalized Anxiety Disorder)

Frequency and extent of psychological distress (Depression) (subjective psycho-oncological support needs) in cancer patients and their relatives and the changes over time

Time Frame: after the diagnosis (up to 8 weeks) and at every follow up (Month 6, Month 12, Month 18)

PHQ (Patient Health Questionnaire - Depression)

Use of psycho-oncological support services by patients and relatives and the changes over time

Time Frame: after the diagnosis (up to 8 weeks) and at every follow up (Month 6, Month 12, Month 18)

Changes in Quality of Life and the changes over time

Time Frame: after the diagnosis (up to 8 weeks) and at every follow up (Month 6, Month 12, Month 18)

EORTC (European Organisation for Research and Treatment of Cancer - Quality of life)

Secondary Outcomes

  • Protective factors and stress-increasing risk factors within the dyad of relatives and the changes over time(after the diagnosis (up to 8 weeks) and at every follow up (Month 6, Month 12, Month 18))

Study Sites (1)

Loading locations...

Similar Trials